Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gentiva Health Services Inc Reaffirms FY 2013 Guidance


Thursday, 9 May 2013 07:00am EDT 

Gentiva Health Services Inc announced that for fiscal 2013, it expects net revenues to be in the range of $1.69 billion to $1.73 billion, including a $21.0 million year-over-year negative impact from branches closed or sold in the prior year. Adjusted income from continuing operations attributable to Gentiva shareholders to be in the range of $0.90 to $1.10 on a diluted per share (EPS) basis, based on an estimated 31.0 million shares outstanding. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.70 billion and EPS of $1.01 for fiscal 2013. 

Company Quote

19.05
-0.1 -0.52%
19 Dec 2014